GKIM
VERA icon

GW&K Investment Management’s Vera Therapeutics VERA Stock Holding History

GW&K Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.58M Sell
89,018
-24,735
-22% -$1.07M 0.03% 284
2025
Q4 		$5.76M Buy
113,753
+36,688
+48% +$1.3M 0.05% 269
2025
Q3 		$2.24M Sell
77,065
-142,963
-65% -$3.31M 0.02% 307
2025
Q2 		$5.18M Sell
220,028
-32,212
-13% -$724K 0.05% 267
2025
Q1 		$6.06M Buy
252,240
+65,635
+35% +$2.11M 0.06% 269
2024
Q4 		$7.89M Buy
+186,605
New +$8.26M 0.07% 269

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GW&K Investment Management's VERA Position: Q1 2026 in Review

GW&K Investment Management reduced its Vera Therapeutics (VERA) stake by 22% in Q1 2026, selling an estimated $1.07M and leaving 89,018 shares worth $3.58M. The position accounts for 0.03% of the portfolio, ranked #284.

GW&K Investment Management first reported a position in VERA in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.89M in Q4 2024. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • GW&K Investment Management held 89,018 shares of Vera Therapeutics worth $3.58M as of Q1 2026.
  • GW&K Investment Management sold 24,735 Vera Therapeutics shares in Q1 2026, an estimated $1.07M.
  • Vera Therapeutics made up 0.03% of GW&K Investment Management's portfolio in Q1 2026, its #284 holding.
  • GW&K Investment Management first reported a position in Vera Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • GW&K Investment Management's Vera Therapeutics position peaked at $7.89M in Q4 2024.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.